Prophylactic Cranial Irradiation for Extensive-Stage Small-Cell Lung Cancer: A Controversial Area

Shuyu Xue; Hanqiao Zeng; Shu Yan; Qianmeng Wang; Xiaojing Jia

doi:10.3389/fonc.2022.772282

Prophylactic Cranial Irradiation for Extensive-Stage Small-Cell Lung Cancer: A Controversial Area

Front Oncol. 2022 Feb 7:12:772282. doi: 10.3389/fonc.2022.772282. eCollection 2022.

Authors

Shuyu Xue¹, Hanqiao Zeng¹, Shu Yan¹, Qianmeng Wang¹, Xiaojing Jia¹

Affiliation

¹ Department of Tumor Radiotherapy, The Second Hospital of Jilin University, Changchun, China.

Abstract

Small-cell lung cancer (SCLC) is a highly aggressive malignant tumor that is prone to lead to the development of brain metastases (BM). The application of prophylactic cranial irradiation (PCI) has been regarded as an important technological advance made in cancer therapy to reduce the occurrence of BM and improve patient survival. The benefits of PCI in the treatment of limited-stage SCLC have been confirmed. However, there has been continuous controversy about the indications and advantages of PCI for extensive-stage SCLC (ES-SCLC) because of the conflicting results from two prospective trials. In this review, we aimed to discuss the relevant controversy and progress made in the clinical application of PCI in ES-SCLC.

Keywords: brain metastasis; extensive disease; prophylactic cranial irradiation; radiotherapy; small-cell lung cancer.

Publication types

Review